Current Concepts in the Management of Relapsed/Refractory Multiple Myeloma: Considerations With Bispecific Anti-BCMA Antibodies
Podcast 1: Management of Multiple Myeloma: Clinical Course and Treatment Options 

Questions marked with a * are required
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
Which of the following options for multiple myeloma are used in patients who have relapsed or not responded to several courses of therapy rather than as initial therapy?
Sharon is a 68-year-old woman with multiple myeloma. In the past, she has received an immunomodulatory agent, a proteosome inhibitor, and a combination therapy that incorporated an anti-CD38 antibody. She presents with another relapse.  What approach would you take? 
Powered by QuestionPro